Fulminant hypercorticism due to ACTG producing pheochromocytoma

Endogenous hypercorticism (EH) is a severe symptom complex caused by hypercortisolemia; according to the etiology, ACTH-dependent and ACTH-independent variants are distinguished, which, according to the literature, occur in 70–80% and 20–30% of cases, respectively. A rare cause of ACTH-dependent endogenous hypercorticism is ACTH-ectopic syndrome (ACTH-ES) (about 15-20% of cases). ACTH-ES is a syndrome of adrenocorticotropic hormone (ACTH) hyperproduction by neuroendocrine tumors of extrahypophyseal origin. Various tumors can secrete ACTH: bronchopulmonary carcinoid, small cell lung cancer, less frequently, thymus carcinoid, islet cell tumors and pancreatic carcinoid, medullary thyroid cancer, carcinoid tumors of the intestine, ovaries, as well as pheochromocytoma (PCC).

This publication presents a clinical case of rarely detected paraneoplastic ACTH production by pheochromocytoma. The patient had clinical manifestations of hypercorticism, therefore, she applied to the Russian National Research Center of Endocrinology of the Ministry of Health of Russia. During the examination Cushing’s syndrome (CS) was confirmed, multispiral computed tomography (MSCT) of the abdominal cavity revealed a voluminous formation of the left adrenal gland. Additional examination recorded a multiple increase in urinary catecholamine levels. Subsequently, the patient underwent left-sided adrenalectomy. The diagnosis of pheochromocytoma was confirmed morphologically, immunohistochemical study demonstrated intensive expression of chromogranin A and ACTH by tumor cells.

1. Young J, Haissaguerre M, Viera-Pinto O, Chabre O, Baudin E, Tabarin A. MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur J Endocrinol. 2020;182(4):R29-R58. doi: https://doi.org/10.1530/EJE-19-0877

2. Кузнецов Н.С., Латкина Н.В., Добрева Е.А. АКТГ-эктопированный синдром: клиника, диагностика, лечение // Эндокринная хирургия. — 2012. — Т. 6. — №1. — С. 24-36

3. Мельниченко Г.А., Трошина Е.А., Бельцевич Д.Г., и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечению феохромоцитомы/параганглиомы // Эндокринная хирургия. — 2015. — Т. 9. — №3. — С. 15-33

4. Кузнецов Н.С., Марова Е.И., Латкина Н.В., и др. АКТГ-продуцирующая феохромоцитома. Клинический случай // Эндокринная хирургия. — 2012. — Т. 6. — №4. — С. 43-50

5. Марова Е.И., Воронкова И.А., Лапшина А.М., и др. Феохромоцитома с эктопической продукцией АКТГ: разбор клинических случаев // Ожирение и метаболизм. — 2015. — Т. 12. — №3. — С. 46-52

6. Gabi JN, Milhem MM, Tovar YE, Karem ES, Gabi AY, Khthir RA. Severe Cushing Syndrome Due to an ACTH-Producing Pheochromocytoma: A Case Presentation and Review of the Literature. J Endocr Soc. 2018;2(7):621-630. doi: https://doi.org/10.1210/js.2018-00086

7. Ершова Е.В., Сенюшкина Е.С., Трошина Е.А. АКТГ-эктопированный синдром у пациента без верифицированной опухоли // Ожирение и метаболизм. — 2018. — Т. 15. — №3. — С. 59-64

8. Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14(2):108–119

9. Seckl JR. 11β-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol. 2004;4(6):597-602. doi: https://doi.org/10.1016/j.coph.2004.09.001

10. David GG, Dolores S. Greenspan’s basic & clinical endocrinology. 8 edition. 2021:p. 461-462

11. Гусейнова Р.М., Пигарова Е.А., Дзеранова Л.К., и др. Лечение АКТГ-эктопированного синдрома октреотидом длительного действия: эффективный контроль активности заболевания // Ожирение и метаболизм. — 2022. — Т. 19. — №2. — С. 180-188

12. Tani Y, Sugiyama T, Izumiyama H, et al. Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between nonpituitary and pituitary ACTH-secreting tumors. Endocrine Journal. 2011;58:297-303

13. Elliott PF, Berhane T, Ragnarsson O, Falhammar H. Ectopic ACTH- and/or CRH-Producing Pheochromocytomas. J Clin Endocrinol Metab. 2021;106(2):598-608. doi: https://doi.org/10.1210/clinem/dgaa488

14. Бельцевич Д.Г., Трошина Е.А., Юкина М.Ю. Феохромоцитома // Проблемы эндокринологии. — 2010. — №1. URL: https://cyberleninka.ru/article/n/feohromotsitoma

15. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–1942

16. Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11(2):101–111

17. Косенко Н.А., Цыганков Б.Д., Косенко В.Г., и др. Психические нарушения при эндокринопатиях // Кубанский научный медицинский вестник. — 2014. — №6. URL: https://cyberleninka.ru/article/n/psihicheskie-narusheniya-pri-endokrinopatiyah